FDA Inspection 1300064 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3015462443

The FDA completed an inspection of Octapharma Plasma Inc on Jan 16, 2026 in Kansas City, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 16, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, KS (United States)

Need the full FDA record for Octapharma Plasma Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.